Although oligomeric b-amyloid (Ab) has been suggested to have an important role in Alzheimer disease (AD), the mechanism(s) of how Ab induces neuronal cell death has not been fully identified. The balance of pro-and anti-apoptotic Bcl-2 family proteins (e.g., Bcl-2 and Bcl-w versus Bad, Bim and Bax) has been known to have a role in neuronal cell death and, importantly, expression levels of these proteins are reportedly altered in the vulnerable neurons in AD. However, the roles of apoptotic proteins in oligomeric Ab-induced cell death remain unclear in vivo or in more physiologically relevant models. In addition, no study to date has examined whether Bax is required for the toxicity of oligomeric Ab. Here, we found that treatment with oligomeric Ab increased Bim levels but decreased Bcl-2 levels, leading to the activation of Bax and neuronal cell death in hippocampal slice culture and in vivo. Furthermore, the inhibition of Bax activity either by Bax-inhibiting peptide or bax gene knockout significantly prevented oligomeric Ab-induced neuronal cell death. These findings are first to demonstrate that Bax has an essential role in oligomeric Ab-induced neuronal cell death, and that the targeting of Bax may be a therapeutic approach for AD.
Previous studies found that expression levels of Bcl-2 family proteins, such as Bax, Bak, Bad, Bcl-2, Bim, Bcl-w and Bcl-x are altered in the vulnerable neurons in AD. 4 Bcl-2 family is structurally defined by the presence of up to four conserved 'BCL-2 homology' (BH) domains. The family proteins are the key regulators of evolutionally conserved pathway of apoptosis. 5, 6 Bax and Bak belong to the multi-BH domains pro-apoptotic subfamily, which promotes apoptosis by translocating into the mitochondrial membrane and facilitating cytochrome c release whereas Bcl-2 and Bcl-XL belong to the prosurvival subfamily, which prevents apoptotic death in multiple cell types including neuron. 7 It is hypothesized that the BH3-only proteins, such as Bim, Bid, Puma, Noxa and Bad induce the activation of Bax and Bak, either directly or indirectly by inactivating the prosurvival Bcl-2 proteins. In the presence of apoptotic stimuli, Bax is known to change its conformation. Specifically, as an early step of Bax activation, the N-terminus exposure is considered a prerequisite for membrane insertion of Bax at mitochondria and multimerization of Bax. 8, 9 Ku70, a DNA repair factor, can prevent the conformational change by binding with Bax in the cytosol, which leads to the inhibition of Bax-mediated cell death. 10 Previously, a cell permeable Bax-inhibiting peptide (BIP), designed to induce the Bax-binding domain of Ku70, was found to rescue cells from Bax-mediated cell death. [10] [11] [12] Notably, overexpression of anti-apoptotic proteins, Bcl-w, or genetic ablation of a proapoptotic effecter, Bim, significantly protected neurons against fibrillar Ab-induced apoptosis in neuroblastoma cell lines and primary neuron culture. 13, 14 Giovanni et al. 15 also reported that fibrillar Ab-induced cell death is dependent on Bax in primary neuron culture. However, these results have never been confirmed in vivo or in a more physiologically relevant model, and all the previous studies examined the toxicity of fibrillar Ab, not oligomeric Ab. Therefore, to advance our understanding of the involvement of Bcl-2 protein family as the major mechanism of oligomeric Ab-induced neuronal cell death, in this study, we examined the effect of oligomeric Ab on the regulation of Bcl-2/Bim/Bax and its functional importance in neuronal cell death in the organotypic hippocampal culture and mouse model for Ab toxicity.
Results
Oligomeric Ab induces Bim upregulation and Bcl-2 downregulation in hippocampal slice culture. To characterize oligomeric Ab in this study, we synthesized Ab peptide, and then denatured the peptide and allowed oligomers to form, as described for Ab-derived diffusible ligands.
1 Consistent with previous findings for oligomeric Ab, 1, 16 our oligomeric Ab preparations contain spherical particles visible by negative staining with transmission electron microscopy, and western blots show that the preparations contain various size of oligomeric proteins (Figure 1) .
Time-dependent changes of the levels of Bax, Bcl-2 and Bim were examined in oligomeric Ab-treated brain slices. Oligomeric Ab increased the expression of Bim but decreased the level of Bcl-2 ( Figure 2a) . However, the level of Bax was not affected by oligomeric Ab (Figure 2a) . As the N-terminus exposure is an early step of Bax activation that occurs in the cytosol, we analyzed this conformational change of Bax with a monoclonal antibody (6A7) recognizing the epitope in the N-terminus of Bax. 9 Although the level of Bax expression was not affected by oligomeric Ab, the number of 6A7-positive cells were significantly increased in oligomeric Ab treated slice cultures (Figure 2b ), suggesting that oligomeric Ab induces Bax activation.
Ablation of Bax reduces oligomeric Ab-induced neuronal cell death in hippocampal slice culture. To further determine the functional role of Bax in oligomeric Abinduced neuronal cell death, hippocampal slice culture prepared from wild-type and bax À / À mice (Figures 3a and b) were used. Slices were treated with oligomeric Ab in the presence of propidium iodide (PI), which penetrates cell membranes of dead or dying cells, and is widely used for evaluation of cell death. Although Ab 42-1 peptide, a reverse sequence of Ab , had no effect on PI uptake, the number of PI-positive cells was significantly increased in oligomeric Ab-treated slices after 48 h of the treatment, indicating that oligomeric Ab induces neuronal cell death in the hippocampal slice culture. However, the neuronal cell death induced by oligomeric Ab was dramatically reduced in the slice culture from bax À / À mice ( Figure 3c ). Nissl staining analysis further confirmed neuronal cell death by oligomeric Ab in wild-type (WT) mouse slice culture but not in bax À / À mouse slice culture (Figure 3d ). These results indicate that Bax is a critical mediator for the neurotoxicity induced by oligomeric Ab.
Intrahippocampal injection of oligomeric Ab increases
Bim expression and active forms of Bax. To further examine the involvement of pro-apoptotic proteins in oligomeric Ab-induced cell death, we determined the change of the levels of Bim and the active form of Bax in vivo. We injected oligomeric Ab into the hippocampus and assessed its neurotoxicity. Ab 42-1 was used as a control. Oligomeric Ab injection into the WT mouse hippocampus induced neuronal cell death in 20 days after injection (Figure 4a ). The number of terminal dUTP nick-end labeling (TUNEL)-positive neurons was significantly increased by Ab injection (Figure 4b) . To see the involvement of Bim and Bax, we measured the level of Bim and active form of Bax, and found that the level of Bim was dramatically increased as early as 10 days after oligomeric Ab injection (Figure 4c ). The number of neurons containing the active form of Bax recognized by 6A7 antibody was also dramatically increased by Ab injection (Figure 4d ). These data further support that both Bim and Bax have roles in oligomeric Ab-induced neuronal cell death.
BIP suppresses neuronal cell death and Bax activation induced by oligomeric Ab in hippocampal slice culture. In this study, in addition to utilizing Bax knockout (KO) mice, we utilized BIP to examine the role of Bax in oligomeric Ab-induced neurotoxicity. BIP used in this study consists of five amino acids, VPTLK, a sequence that is known to inhibit Bax activation. 10, 11, 17 A mutated (scrambled) peptide, KLVPT, which does not bind Bax but has the same cell permeability, was used as a negative control. Both peptides were tagged with fluorescein isothiocyanate (FITC) so that intracellular delivery can be tracked by FITC signal. We first treated hippocampal slices with each peptide and analyzed green fluorescence to confirm their cell permeability, and confirmed that BIP and the control peptide equally penetrated neuronal cells after 24-h treatment (Figure 5a ). To determine whether BIP is able to suppress oligomeric Abinduced neuronal cell death in slice culture, either BIP or control peptide were co-applied with oligomeric Ab. After 24-h treatment of oligomeric Ab and the peptide, the treatment of BIP significantly prevented PI uptake, whereas the control peptide did not affect the level of PI uptake (Figure 5b ), suggesting BIP specifically blocks neuronal cell death induced by oligomeric Ab. Consistent with the PI uptake results, both Nissl staining and caspase-3 immunoblot analyses also showed that BIP significantly suppressed oligomeric Ab-induced neuronal loss and caspase-3 activation, but control peptide failed to prevent neuronal cell death (Figures 5c and d) . We also found that the treatment of BIP suppresses oligomeric Ab-induced conformational change of Bax ( Figure 6 ). These results further support the hypothesis 
Discussion
In this study, we demonstrate that oligomeric Ab altered the expression levels of Bcl-2, Bim and Bax, and that the genetic or pharmacological ablation of Bax activity suppresses oligomeric Ab-mediated neurotoxicity in both ex vivo and in vivo. These results clearly indicate that Bax has an essential role in the induction of neuronal cell death caused by oligomeric Ab.
In healthy cells, Bax is located in the cytosol or loosely associated to mitochondria and endoplasmic reticulum. 18 Bax translocation to the mitochondria, which occurs in cells with apoptotic stresses, is thought to lead to mitochondrial dysfunction and release of cytochrome c and subsequent apoptosis. 19 Before its translocation to mitochondria, Bax changes its conformation that exposes the N-terminal residues. 20 This conformational change is believed to be necessary for membrane insertion of Bax at mitochondria and multimerization of Bax. 21 The present study demonstrates that oligomeric Ab induced the N-terminal exposure of Bax in neurons and that the inhibition of this event by BIP rescues neurons from oligomeric Ab's neurotoxicity, suggesting the activation of Bax by its conformational change is a key element of oligomeric Ab-induced neurotoxicity.
Although the molecular mechanism(s) of Bax activation has not been clearly defined, multiple pro-apoptotic proteins (e.g., Bim) and anti-apoptotic proteins (e.g., Bcl-2) are known to regulate the activation of Bax thorough heterodimerization. 22 In fact, consistent with the previous findings, our current data demonstrate that the level of Bim is significantly upregulated after oligomeric Ab treatment, whereas anti-apoptotic protein Bcl-2 is downregulated, suggesting that oligomeric Ab induces neuronal cell death through the alteration of the balance of Bcl-2 family proteins and consequent activation of Bax. Unlike most 'BH3-only' proteins, Bim can interact with all pro-survival Bcl-2 proteins with high affinity, and is one of the few BH3-only proteins that can directly activate Bax. 23 For instance, several in vitro data suggested that the direct physical interaction between Bim and Bax can drive Bax activation. 24, 25 Importantly, the ablation of Bim suppresses Ab-induced cell death in primary neurons, 13 and overexpression of anti-apoptotic proteins (Bcl-w) significantly protected neurons against Ab-induced apoptosis.
14 Previous reports suggested that overexpression of Bim in cultured neurons induces a rapid apoptotic death 26 and Bim is highly expressed in AD neurons. 13 Bim is also known to induce Bax activation directly or indirectly. 27 Collectively, these data strongly However, it remains unknown how oligomeric Ab activates Bim and consequent neuronal cell death. Although future study will be required to determine the mechanism, one potential pathway might be c-Jun N-terminal kinase (JNK)-dependent phosphorylation, as JNK-mediated phosphorylation promotes Bax-dependent apoptosis. 28 As the activation of JNK by Ab has been shown 29 and the active form of JNK has been reported to be increased in vulnerable neurons in AD, 30 it is plausible that the activation of JNK and subsequent activation of Bim/Bax-mediated apoptosis pathway might be the mechanism causing neuronal cell death in oligomeric Abtreated neurons and AD. Alternately, cyclin-dependent kinase 4 (Cdk4) has been suggested as an activator of Bim. Induction of Bim in nerve growth factor-deprived neuronal cells requires active Cdk4 and consequent reactivation of a series of genes suppressed by E2F. 31 Among the reactivated genes, members of the myb transcription factor family, especially c-myb, seem to have a role in the activation of Bim. In previous studies, the inhibition of Cdk by various experimental approaches (i.e., chemical inhibitors, dominant-negative constructs, small interfering RNA) provide further evidence for the role of Cdk4 in the induction of Bim and neuronal cell death evoked by Ab. 13, 15, 32 Given that the elevated expression of cell cycle-related proteins including Cdk4 is evident in the vulnerable neurons in AD [33] [34] [35] and Ab-treated neuronal cells, 32, 36 an abortive reentry into the cell cycle might induce neuronal cell death by upregulating Bim/Bax apoptotic pathway. Supporting the causal role of cell cycle reentry in neuronal cell death, we previously found that dysregulation of cell cycle reentry results in neurodegeneration in vivo. 37 Although we did not examine mRNA level of Bim and its posttranslational change, a previous report demonstrated that fibrillar Ab increases the level of Bim mRNA and protein. 13 Thus, the increase of Bim expression by Ab is likely mediated by transcriptional regulation. However, the increased translational modification such as phosphorylation of Bim might also be the reason for the increase of band intensity in our western blot data (Figure 2a) . In fact, the western blot bands for upregulated Bim have a slightly higher molecular weight and this change may come from the phosphorylation of Bim, as Bim is known to be phosphorylated by several kinases. Cdk1/ Cyclin B1 is one of the kinases to phosphorylate Bim. 38 Interestingly, in our recent study (manuscript in preparation), we found that Ab induced abnormal cell cycle upregulation as well as Cdk's activation and these events may have a role in posttranslational modification of Bim as seen in this study. Furthermore, the phosphorylation of Bim has been suggested to regulate Bax-dependent cell death. 28 Therefore, the modification may regulate the apoptotic activity in our model. In future study, we will pursue the link between Cdk and Bim in Ab neurotoxicity.
The present study showing Bax activation by oligomeric Ab and the resistance of bax À / À neurons to oligomeric Ab cell death suggest that Bax is a key mediator of oligomeric Ab toxicity, and therefore BIP's protective effects against oligomeric Ab can be translated as the result of Bax inhibition. BIP was developed as a Bax-inhibiting peptide, however, as usual in any type of drug, we cannot entirely exclude the possibility that BIP has unexpected target(s) in the cell, which can regulate cellular response to oligomeric Ab. The future study developing therapeutics based on BIP will need further careful examination of the possibilities of the existence of the target(s) of BIP in addition to Bax.
In conclusion, in this study, we found that bax À / À mice are resistant to oligomeric Ab-induced neuronal cell death, suggesting the essential role of Bax in neurotoxicity of oligomeric Ab. Furthermore, we show for the first time that BIP application prevents oligomeric Ab-induced neuronal cell death, suggesting that BIP and its mimetics may be utilized to mitigate the progress of AD by rescuing neurons from Baxinduced cell death. Our study also suggests that oligomeric Ab regulates the activity of Bim, Bcl-2 and Bax in neurons. Taken all together, it is highly likely that the activation of Bax by the regulation of Bim and Bcl-2 family is crucial for oligomeric Ab-induced neuronal cell death. Preparation of oligomeric Ab. Soluble oligomeric Ab was prepared from synthetic peptide according to a previous paper. 39 Briefly, 1 mg of Ab 1-42 peptide was dissolved in 120 ml of hexafluoroisopropanol for 60 min at room temperature, and placed back on ice for 5-10 min. After evaporation of hexafluoroisopropanol overnight in the hood at room temperature, the peptide was dissolved in 40 ml of fresh anhydrous DMSO, and further diluted to 5 mM stock solution. The stock peptide solution was then incubated for 24 h at 4 1C, and centrifuged at 14 000 Â g for 10 min at 4 1C. Supernatant was used as oligomeric Ab. Before we treated slice culture with oligomeric Ab, the oligomers were incubated at room temperature for 20 h.
Mouse strains. Bax KO mice (strain name: B6.129 Â 1-Bax t m1Sjk /J.) were purchased from The Jackson Laboratories (Bar Harbor, ME, USA). This Bax KO mouse has C57BL/6 genetic background. Bax KO mice were crossed with wild-
Aβ1-42
Aβ/VPTLK 6A7 DAPI Merge Control (Aβ42-1) Figure 6 BIP prevents the conformational change of Bax induced by oligomeric Ab. BIP (VPTLK) was treated to hippocampal slice cultures with oligomeric Ab for 48 h. Ab 42-1 was used as a control. The slices were stained with 6A7 antibody for detecting active conformational change of Bax. In the BIP-treated slices, the number and intensity of 6A7-positive signal (green) was significantly decreased compared with the slices treated with Ab only. Scale bar, 100 mm type C57BL/6 mice, and bax þ / À mouse colony was generated. Bax KO as well as WT mice used for this study were generated by crossing bax þ / À mice in our mouse colony. Each experiment used a set of Bax KO and WT mice obtained from the same parent to minimize variations caused by genetical differences among mice. bax À / À mice were genotyped by PCR, as described previously. The primers for the wild-type and KO Bax alleles were 5 0 -GAGCTGATCAGAACCAT CATG-3 0 (sense) and 5 0 -CCGCTTCCATTGCTCAGCGG-3 0 (antisense). Conditions were set as follows: 941 C, 3 min (1 cycle); 941 C, 30 s, 631 C, 1 min, 721 C, 1 min (35 cycles); 721 C, 2 min (1 cycle). All protocols involving the use of mice were approved by the Institutional Animal Care and Use Committee of Case Western Reserve University.
Electron microscopy. Ab 1-42 was adsorbed onto carbon films supported on Formvar (EMS, Hatfield, PA, USA) membrane-coated nickel grids. The excess buffered-protein solution was removed, and negatively stained with 2% uranyl acetate. Grids were then washed by touching the buffer and the excess buffer was immediately blotted using Whatman (Picataway, NJ, USA) filter paper. Grids were then air-dried and kept at room temperature. Negatively stained specimens were observed by a JEOL 1200EX electron microscope (JEOL, Tokyo, Japan) with 80 kV of electron acceleration voltage.
Preparation of organotypic hippocampal slice cultures. Organotypic hippocampal slice cultures were prepared as described previously. 40 Briefly, hippocampal slice cultures were prepared using 7-10-day-old mouse pups. Slices were cut at 400 mm on a Mcllwain tissue chopper, transferred to Millicell membrane inserts (0.4 mm; Millipore), and placed in 6-well culture plates. The culture medium consisted of basal Eagle's medium with Earle's balanced salt solution, 20% heat-inactivated horse serum, enriched with 5.6 mM glucose. The medium was changed every other day. The effect of oligomeric Ab (500 nM) was tested in the slices that had been maintained for 11-14 days in vitro. Ab oligomer or reversed sequence of Ab 1-42 control peptide (Ab ) was added to cultures in serum-free medium and, after the treatment, the hippocampal slices were rinsed twice in ice-cold phosphate-buffered saline (PBS), and then harvested by removing the Millicell membrane insert.
Assessment of neuronal cell death in organotypic hippocampal slice cultures. To determine neuronal cell death in the hippocampal slices, PI (5 mg/ml) was added to the slice culture medium. Images were acquired through an AxioCam camera on an Axiovert 200M microscope (Zeiss, Oberkochen, Germany). Fluorescent intensity was measured using Image J (NIH, Bethesda, MD, USA). Hematoxylin and eosin (H&E) and Nissl staining was also performed for routine histochemical and morphological analyses.
Protein extraction and western blot analysis. After oligomeric Ab treatment, the slices were rinsed twice with ice-cold PBS and then lysed in ice-cold cell lysis buffer (Cell Signaling Technology) with protease and phosphatase inhibitor cocktail (Roche, Indianapolis, IN, USA). The protein concentration was determined by BCA assay (Pierce, Rockford, IL, USA). The extracted proteins were separated on 10 or 12% SDS-polyacrylamide gel and transferred onto polyvinylidene difluoride membranes. The blots were blocked with 10% non-fat milk in TBS-T for 1 h at room temperature, and then treated with primary antibodies diluted with 1% non-fat milk and incubated overnight at 4 1C. The following antibodies were used for western blot analysis: anti-caspase-3 (1 : 1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Bim (1 : 1000; Stressgen, Farmingdale, NY, USA), anti-Bcl-2 (1 : 1000; Stressgen) and 6A7 (conformational specific Bax antibody) (1 : 1000; BD Pharmingen, San Diego, CA, USA).
Intrahippocampal injection of oligomeric Ab. C57BL6/J mice (The Jackson Laboratories; 2-3-month-old) were anesthetized with pentobarbital and placed in a stereotaxic frame. Injection was made using a 10-ml microsyringe (Hamilton, Reno, NV, USA). A volume of 1 ml of oligomeric Ab dissolved at 50 mM in PBS was injected into the left hippocampus. Control animals were prepared identically and injected with the same volume and concentration of Ab 42-1 in PBS. Injections were made at stereotaxic coordinates from bregma; antereoposterior (AP) ¼ 2.3 mm, mediolateral (ML) ¼ 2.5 mm and doroventral (DV) ¼ À 2.5 mm according to a previous report. 41 This corresponds to a site in the dorsal hippocampus in the apical dendritic zones of the CA1 region near the hippocampal fissure. Mice were killed 10 or 20 days after injection, brains dissected out, fixed in 10% buffered-formalin and paraffin-embedded. For brain tissue sections, 6-mm-thick serial sections were cut, mounted onto slides and rehydrated according to standard protocols.
Immunocytochemistry. Cultured hippocampal slices were rinsed with icecold PBS once and fixed for 2 h with 4% paraformaldehayde in 0.1 M PBS. 42 After washing with PBS, sections were permeabilized overnight with PBS containing 0.2% Triton X-100. At the end of the permeabilization blocking solution, 10% normal goat serum in PBS was applied for 4 h at room temperature. After washing with PBS, primary antibody was added and incubated for 24-48 h at 4 1C. After thorough washing of the sections in PBS, a secondary antibody labeled with either Alexa Fluor (Life Technologies, Grand Island, NY, USA) 488 or 568 (1 : 300) was added and incubated for 4 h at room temperature. All of the experiments contained at least one sample incubated without a primary antibody to exclude non-specific signal. Nuclei were visualized with DAPI. Images were acquired through an AxioCam camera on an Axiovert 200M microscope (Zeiss). Images were then analyzed with the Axiovision software (Zeiss).
TUNEL analysis. Detection of 3
0 -OH termini of DNA strand breaks was performed using in situ cell death detection kit (Roche). Briefly, the tissue sections were treated with proteinase K (20 mg/ml in 10 mmol/l Tris-HCl, pH 7.4) for 30 min at 37 1C after rehydration. After rinsing with PBS, TUNEL reaction mixture containing terminal deoxynucleotidyl transferase and fluorescence-labeled nucleotide was applied for 1 h 37 1C. The samples were then washed and mounted using Aquamount (Southern Biotech, Birmingham, AL, USA).
Statistical analysis. Data were expressed as the means ± S.E.; the number of independent experiments is indicated in the corresponding figure legend. Differences between groups were examined for statistical significance using one-way analysis of variance with an unpaired Student's t-test. A P value of o0.05 indicated a statistically significant difference.
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